Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,652,087
-$336,853 QoQ
Shares Held
64,733
+1.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $41,564,859 across 6 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
387,867 | $12,179,023 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
109,942 | $9,100,998 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
310,768 | $7,648,000 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
36,763 | $6,196,036 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
93,032 | $4,397,622 | |
| 6 | ALKS |
Alkermes plc.
|
38,992 | $2,043,180 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,652,087 | 64,733 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,988,940 | 63,495 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,381,502 | 57,282 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,948,518 | 63,793 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,794,783 | 65,562 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,234,512 | 68,953 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $12,156,543 | 62,220 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,033,388 | 40,571 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $6,899,199 | 40,773 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,100,459 | 41,042 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $7,089,337 | 40,748 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $7,665,067 | 44,510 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $7,358,312 | 44,210 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,954,237 | 47,453 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,870,423 | 46,331 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,415,162 | 43,139 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,364,343 | 44,352 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,011,330 | 41,025 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $8,108,257 | 41,765 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,682,691 | 41,225 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $7,607,071 | 48,305 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,855,077 | 53,505 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,995,962 | 54,399 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $8,184,576 | 59,724 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $5,372,430 | 45,649 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||